Contributors
Latest:
An Oncology Nurse Who Is Always Glad to Answer CallsIt is that one-to-one communication that allows Kimberly Rosencrance, B.S.N., RN, OCN, to excel as an oncology nurse.
Latest:
Starting Early and Staying Late: Dedication to Patients With CancerAn Extraordinary Healer essay honoring Kim-Chi Pham, RN, OCN [Harris Health System – Lyndon B. Johnson General Hospital in Houston, Texas]
Latest:
Chan Zuckerberg Initiative Awards Fibrolamellar Cancer Foundation First Ever "Rare As One Network" GrantThe Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare disease organizations, including rare cancer foundations, to receive the first CZI Rare As One Network grant.
Latest:
A Strange New World of Cancer Research Has a CostMy genetic testing covered 648 gene variants. Of course, researchers only know the significance of a fraction of those variants.
Latest:
Novel Drug Induces Robust Responses in von-Hippel Lindau Disease-Associated Kidney CancerAt a median follow-up of almost two years, 88.5% of patients remained on study treatment.
Latest:
Participating in a Lung Cancer Registry Can Be EmpoweringLung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.
Latest:
Who Should Be Tested for a BRCA Mutation? The Science Is EvolvingClinical genetics experts see value in testing more women for BRCA mutations.
Latest:
MPN Hero Advocates for Her Daughter Until The Right Diagnosis Is MadeFor Natalie Catalano, caregiving for her daughter with essential thrombocythemia included not only being a rock of support, but also being a vocal advocate for her daughter’s care team to make the right diagnosis.
Latest:
Compassionate Cancer Care That Began With a HugAn Extraordinary Healer essay honoring Annie Nelson, RN, MSN [ Sanford Cancer Center and Center for Digestive Health in Sioux Falls, South Dakota ]
Latest:
Caring for the Cancer CaregiverThose acting as caregivers to patients with cancer often face their own set of hardships.
Latest:
Managing Cancer Scares During a PandemicNavigating the scary path of a cancer caregiver possibly becoming the patient with cancer.
Latest:
Colleen M. O'Leary on How Patients Can Manage Oral MucositisColleen M. O'Leary, RN, MSN, AOCNS, from The James Cancer Hospital, The Ohio State University, discusses how patients can manage oral mucositis.
Latest:
Two-Drug Combo Improves Post-Transplant Myeloma OutcomesA two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.
Latest:
Defining Cancer SurvivorshipWhen does a patient become a survivor of cancer? Some believe it’s at the moment of diagnosis, but others disagree.
Latest:
Every Time I Think I Have CancerYou know that saying “when you are sick, the internet is not your friend”? Well, that’s a fact. I start looking up runny nose, and because I believe that the runny substance coming from my nose must be spinal fluid, I must have brain cancer.
Latest:
Journaling Through ConfinementAn author who journaled while homebound after cancer treatment has created a book of writing prompts for those who are staying put during the COVID-19 pandemic.
Latest:
Nanotechnology-Enabled Cancer Treatments and DiagnosticsThe National Cancer Institute launched its Alliance for Nanotechnology in Cancer with the goal of using nanomedicine to change the way cancer is treated.
Latest:
Front-Line Imbruvica-Venclexta Combo May Induce Durable Responses in Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaTreatment with this combination was associated with encouraging clinical responses in this patient population.
Latest:
The Administration's Drug Rebate Proposal: An Opportunity to Put Patients FirstOf all the health care regulations coming out of the current administration, the recent drug rebate proposal presents a new opportunity to significantly lower out-of-pocket prescription drug costs for Medicare patients. But like most things in health care, there is more complexity to the administration’s proposed changes to pharmaceutical company rebates than initially meets the eye.
Latest:
Examining the Safety of CLL MedicationOVER THE LAST FEW years, significant advances were made in the treatment of patients with chronic lymphocytic leukemia (CLL). Several novel therapies, most of them oral, have now been approved by the Food and Drug Administration. These include Imbruvica (ibrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor; Venclexta (venetoclax), a B-cell lymphoma-2 (BCL2) inhibitor; and Zydelig (idelalisib), a phosphoinositide 3-kinase (PI3K) inhibitor.
Latest:
The Importance of Biomarker Testing for Patients and Their FamiliesUnderstanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.
Latest:
One Million and Counting ... in Support of Bladder Cancer ResearchWhen my late husband John and I started the Bladder Cancer Advocacy Network (BCAN) in 2005, our goal was not only to raise awareness about bladder cancer, but to change the landscape for this disease by funding research to discover new treatments that will save lives.
Latest:
Web Tools Help Men Deal with Side Effects of Cancer TreatmentAn online tool is designed to help men with prostate or other types of cancer deal with sexual dysfunction and other common side effects of treatment.
Latest:
Looking At Yourself Differently After CancerMoment by moment, we move toward life. We feel what needs to be felt. We can even feel through the numb parts—the broken pieces. Instead of looking somewhere else, we look straight on— at ourselves and others. We see what’s really there. Who is there for us? Who is not? We choose to be with those we love, and those who love us back—like the person in the mirror, the new friend.
Latest:
'CURE Expert Connections' Launches 'An Opportunity for Treatment in Relapsed Hairy Cell Leukemia' Video SeriesA patient and a physician discuss the treatment landscape of hairy cell.
